Cevimeline Hydrochloride

Cevimeline Hydrochloride is a prescription medication primarily used to alleviate symptoms of dry mouth. This article provides a comprehensive overview of its mechanism of action, therapeutic uses, dosage guidelines, and potential side effects, offering essential information for patients and healthcare professionals.

Cevimeline Hydrochloride

Key Takeaways

  • Cevimeline Hydrochloride is a cholinergic agonist that stimulates muscarinic receptors.
  • It is primarily prescribed for the treatment of xerostomia (dry mouth) associated with Sjögren’s syndrome.
  • The medication works by increasing the secretion of saliva and other exocrine fluids.
  • Common side effects include increased sweating, nausea, diarrhea, and blurred vision.
  • Dosage should be individualized and taken as directed by a healthcare provider, typically three times daily.

What is Cevimeline Hydrochloride: Mechanism of Action

Cevimeline Hydrochloride is a synthetic muscarinic agonist that selectively stimulates M1 and M3 muscarinic receptors. This selective action is crucial for its therapeutic effect, as it primarily targets the receptors found in exocrine glands, such as the salivary and lacrimal glands. By binding to these receptors, cevimeline hydrochloride enhances the secretion of various bodily fluids, including saliva, tears, and sweat.

The cevimeline hydrochloride mechanism of action involves mimicking the effects of acetylcholine, a natural neurotransmitter responsible for parasympathetic nervous system activity. This stimulation leads to an increase in glandular secretion, which helps to alleviate symptoms of dryness. Its relatively selective action on muscarinic receptors in exocrine glands helps to minimize systemic side effects compared to non-selective cholinergic agonists.

Cevimeline Hydrochloride Uses and Dosage Information

Cevimeline Hydrochloride is predominantly prescribed for the treatment of xerostomia, commonly known as dry mouth, particularly in patients diagnosed with Sjögren’s syndrome. Sjögren’s syndrome is an autoimmune disorder characterized by dry eyes and dry mouth due to impaired function of the lacrimal and salivary glands. By increasing saliva production, cevimeline hydrochloride helps to improve oral comfort, facilitate chewing and swallowing, and reduce the risk of dental complications associated with chronic dry mouth.

Regarding cevimeline hydrochloride dosage information, the typical recommended dose for adults is 30 mg, taken three times daily. It is generally advised to take the medication with or without food. However, the exact dosage and frequency may vary based on the individual’s response to treatment, the severity of symptoms, and the presence of any underlying medical conditions. Patients should always follow their healthcare provider’s instructions carefully and not adjust their dose without medical advice. Consistent use is important for optimal therapeutic benefits.

Cevimeline Hydrochloride Side Effects and Precautions

Like all medications, Cevimeline Hydrochloride can cause side effects, though not everyone experiences them. The most common cevimeline hydrochloride side effects are generally related to its cholinergic activity and include:

  • Increased sweating (diaphoresis)
  • Nausea
  • Diarrhea
  • Blurred vision
  • Headache
  • Dizziness
  • Rhinitis (runny nose)

Less common but more serious side effects can include bradycardia (slow heart rate), hypertension (high blood pressure), and urinary frequency. Cevimeline Hydrochloride is contraindicated in patients with uncontrolled asthma, narrow-angle glaucoma, or acute iritis, as it can exacerbate these conditions. Caution is advised for individuals with severe cardiovascular disease, chronic obstructive pulmonary disease (COPD), or cholelithiasis (gallstones), as the medication may worsen these conditions. Patients should inform their doctor about all existing medical conditions and other medications they are taking before starting treatment with cevimeline hydrochloride.

[EN] Cancer Types

Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday


By filling out this form, you’re consenting only to release your medical records. You’re not agreeing to participate in clinical trials yet.